nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Raloxifene—osteoporosis	0.0876	0.137	CbGbCtD
Ropivacaine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0846	0.132	CbGbCtD
Ropivacaine—CYP1A2—Estropipate—osteoporosis	0.077	0.12	CbGbCtD
Ropivacaine—CYP2B6—Cholecalciferol—osteoporosis	0.0676	0.106	CbGbCtD
Ropivacaine—CYP3A4—Calcitriol—osteoporosis	0.0403	0.063	CbGbCtD
Ropivacaine—CYP3A4—Estropipate—osteoporosis	0.0403	0.063	CbGbCtD
Ropivacaine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0364	0.0569	CbGbCtD
Ropivacaine—CYP2D6—Cholecalciferol—osteoporosis	0.0327	0.051	CbGbCtD
Ropivacaine—CYP3A4—Ergocalciferol—osteoporosis	0.0322	0.0504	CbGbCtD
Ropivacaine—CYP1A2—Estradiol—osteoporosis	0.032	0.0499	CbGbCtD
Ropivacaine—CYP3A4—Raloxifene—osteoporosis	0.0269	0.042	CbGbCtD
Ropivacaine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.026	0.0406	CbGbCtD
Ropivacaine—CYP3A4—Cholecalciferol—osteoporosis	0.0208	0.0325	CbGbCtD
Ropivacaine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0191	0.0298	CbGbCtD
Ropivacaine—CYP3A4—Estradiol—osteoporosis	0.0167	0.0262	CbGbCtD
Ropivacaine—Loss of consciousness—Zoledronate—osteoporosis	0.000326	0.000955	CcSEcCtD
Ropivacaine—Hypersensitivity—Estropipate—osteoporosis	0.000325	0.000952	CcSEcCtD
Ropivacaine—Thrombocytopenia—Pamidronate—osteoporosis	0.000325	0.00095	CcSEcCtD
Ropivacaine—Urinary tract disorder—Estradiol—osteoporosis	0.000324	0.00095	CcSEcCtD
Ropivacaine—Vomiting—Etidronic acid—osteoporosis	0.000324	0.00095	CcSEcCtD
Ropivacaine—Cough—Zoledronate—osteoporosis	0.000324	0.000948	CcSEcCtD
Ropivacaine—Oedema peripheral—Estradiol—osteoporosis	0.000324	0.000947	CcSEcCtD
Ropivacaine—Tachycardia—Pamidronate—osteoporosis	0.000324	0.000947	CcSEcCtD
Ropivacaine—Urethral disorder—Estradiol—osteoporosis	0.000322	0.000943	CcSEcCtD
Ropivacaine—Rash—Etidronic acid—osteoporosis	0.000322	0.000942	CcSEcCtD
Ropivacaine—Convulsion—Zoledronate—osteoporosis	0.000322	0.000941	CcSEcCtD
Ropivacaine—Dermatitis—Etidronic acid—osteoporosis	0.000321	0.000941	CcSEcCtD
Ropivacaine—Vertigo—Conjugated Estrogens—osteoporosis	0.000321	0.00094	CcSEcCtD
Ropivacaine—Hyperhidrosis—Pamidronate—osteoporosis	0.000321	0.000938	CcSEcCtD
Ropivacaine—Syncope—Conjugated Estrogens—osteoporosis	0.00032	0.000938	CcSEcCtD
Ropivacaine—Hypertension—Zoledronate—osteoporosis	0.00032	0.000938	CcSEcCtD
Ropivacaine—Hypersensitivity—Alendronate—osteoporosis	0.00032	0.000938	CcSEcCtD
Ropivacaine—Headache—Etidronic acid—osteoporosis	0.00032	0.000936	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000318	0.00093	CcSEcCtD
Ropivacaine—Asthenia—Estropipate—osteoporosis	0.000317	0.000927	CcSEcCtD
Ropivacaine—Arthralgia—Zoledronate—osteoporosis	0.000316	0.000925	CcSEcCtD
Ropivacaine—Myalgia—Zoledronate—osteoporosis	0.000316	0.000925	CcSEcCtD
Ropivacaine—Chest pain—Zoledronate—osteoporosis	0.000316	0.000925	CcSEcCtD
Ropivacaine—Insomnia—Risedronate—osteoporosis	0.000316	0.000924	CcSEcCtD
Ropivacaine—Anxiety—Zoledronate—osteoporosis	0.000315	0.000922	CcSEcCtD
Ropivacaine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000314	0.000919	CcSEcCtD
Ropivacaine—Paraesthesia—Risedronate—osteoporosis	0.000313	0.000917	CcSEcCtD
Ropivacaine—Pruritus—Estropipate—osteoporosis	0.000312	0.000914	CcSEcCtD
Ropivacaine—Discomfort—Zoledronate—osteoporosis	0.000312	0.000914	CcSEcCtD
Ropivacaine—Asthenia—Alendronate—osteoporosis	0.000312	0.000913	CcSEcCtD
Ropivacaine—Hypersensitivity—Ibandronate—osteoporosis	0.000312	0.000913	CcSEcCtD
Ropivacaine—Cough—Conjugated Estrogens—osteoporosis	0.000312	0.000913	CcSEcCtD
Ropivacaine—Dyspnoea—Risedronate—osteoporosis	0.000311	0.00091	CcSEcCtD
Ropivacaine—Hypotension—Pamidronate—osteoporosis	0.00031	0.000907	CcSEcCtD
Ropivacaine—Convulsion—Conjugated Estrogens—osteoporosis	0.00031	0.000906	CcSEcCtD
Ropivacaine—Pruritus—Alendronate—osteoporosis	0.000308	0.0009	CcSEcCtD
Ropivacaine—Dyspepsia—Risedronate—osteoporosis	0.000307	0.000899	CcSEcCtD
Ropivacaine—Tinnitus—Estradiol—osteoporosis	0.000306	0.000897	CcSEcCtD
Ropivacaine—Constipation—Ethinyl Estradiol—osteoporosis	0.000306	0.000896	CcSEcCtD
Ropivacaine—Confusional state—Zoledronate—osteoporosis	0.000305	0.000894	CcSEcCtD
Ropivacaine—Hypersensitivity—Calcitriol—osteoporosis	0.000305	0.000894	CcSEcCtD
Ropivacaine—Cardiac disorder—Estradiol—osteoporosis	0.000305	0.000893	CcSEcCtD
Ropivacaine—Chest pain—Conjugated Estrogens—osteoporosis	0.000304	0.000891	CcSEcCtD
Ropivacaine—Myalgia—Conjugated Estrogens—osteoporosis	0.000304	0.000891	CcSEcCtD
Ropivacaine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000304	0.000891	CcSEcCtD
Ropivacaine—Asthenia—Ibandronate—osteoporosis	0.000304	0.000889	CcSEcCtD
Ropivacaine—Anxiety—Conjugated Estrogens—osteoporosis	0.000303	0.000887	CcSEcCtD
Ropivacaine—Nausea—Etidronic acid—osteoporosis	0.000303	0.000887	CcSEcCtD
Ropivacaine—Anaphylactic shock—Zoledronate—osteoporosis	0.000303	0.000887	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000302	0.000884	CcSEcCtD
Ropivacaine—Diarrhoea—Estropipate—osteoporosis	0.000302	0.000884	CcSEcCtD
Ropivacaine—Infection—Zoledronate—osteoporosis	0.000301	0.000881	CcSEcCtD
Ropivacaine—Insomnia—Pamidronate—osteoporosis	0.0003	0.000878	CcSEcCtD
Ropivacaine—Pruritus—Ibandronate—osteoporosis	0.000299	0.000877	CcSEcCtD
Ropivacaine—Pain—Risedronate—osteoporosis	0.000298	0.000873	CcSEcCtD
Ropivacaine—Constipation—Risedronate—osteoporosis	0.000298	0.000873	CcSEcCtD
Ropivacaine—Shock—Zoledronate—osteoporosis	0.000298	0.000872	CcSEcCtD
Ropivacaine—Paraesthesia—Pamidronate—osteoporosis	0.000298	0.000872	CcSEcCtD
Ropivacaine—Diarrhoea—Alendronate—osteoporosis	0.000297	0.000871	CcSEcCtD
Ropivacaine—Asthenia—Calcitriol—osteoporosis	0.000297	0.00087	CcSEcCtD
Ropivacaine—Thrombocytopenia—Zoledronate—osteoporosis	0.000297	0.000868	CcSEcCtD
Ropivacaine—Dyspnoea—Pamidronate—osteoporosis	0.000296	0.000865	CcSEcCtD
Ropivacaine—Tachycardia—Zoledronate—osteoporosis	0.000296	0.000865	CcSEcCtD
Ropivacaine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000295	0.000863	CcSEcCtD
Ropivacaine—Chills—Estradiol—osteoporosis	0.000295	0.000863	CcSEcCtD
Ropivacaine—Somnolence—Pamidronate—osteoporosis	0.000295	0.000863	CcSEcCtD
Ropivacaine—Skin disorder—Zoledronate—osteoporosis	0.000294	0.000861	CcSEcCtD
Ropivacaine—Pruritus—Calcitriol—osteoporosis	0.000293	0.000858	CcSEcCtD
Ropivacaine—Hyperhidrosis—Zoledronate—osteoporosis	0.000293	0.000857	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000293	0.000856	CcSEcCtD
Ropivacaine—Diarrhoea—Raloxifene—osteoporosis	0.000293	0.000856	CcSEcCtD
Ropivacaine—Dyspepsia—Pamidronate—osteoporosis	0.000292	0.000854	CcSEcCtD
Ropivacaine—Dizziness—Estropipate—osteoporosis	0.000292	0.000854	CcSEcCtD
Ropivacaine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000292	0.000854	CcSEcCtD
Ropivacaine—Infection—Conjugated Estrogens—osteoporosis	0.00029	0.000848	CcSEcCtD
Ropivacaine—Diarrhoea—Ibandronate—osteoporosis	0.00029	0.000848	CcSEcCtD
Ropivacaine—Mental disorder—Estradiol—osteoporosis	0.000288	0.000843	CcSEcCtD
Ropivacaine—Dizziness—Alendronate—osteoporosis	0.000288	0.000842	CcSEcCtD
Ropivacaine—Shock—Conjugated Estrogens—osteoporosis	0.000287	0.00084	CcSEcCtD
Ropivacaine—Erythema—Estradiol—osteoporosis	0.000286	0.000837	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Risedronate—osteoporosis	0.000285	0.000835	CcSEcCtD
Ropivacaine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000285	0.000833	CcSEcCtD
Ropivacaine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000284	0.000832	CcSEcCtD
Ropivacaine—Pain—Pamidronate—osteoporosis	0.000284	0.00083	CcSEcCtD
Ropivacaine—Constipation—Pamidronate—osteoporosis	0.000284	0.00083	CcSEcCtD
Ropivacaine—Diarrhoea—Calcitriol—osteoporosis	0.000284	0.00083	CcSEcCtD
Ropivacaine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000283	0.000829	CcSEcCtD
Ropivacaine—Hypotension—Zoledronate—osteoporosis	0.000283	0.000828	CcSEcCtD
Ropivacaine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000283	0.000828	CcSEcCtD
Ropivacaine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000283	0.000828	CcSEcCtD
Ropivacaine—Dizziness—Raloxifene—osteoporosis	0.000283	0.000828	CcSEcCtD
Ropivacaine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000282	0.000825	CcSEcCtD
Ropivacaine—Tension—Estradiol—osteoporosis	0.000281	0.000822	CcSEcCtD
Ropivacaine—Vomiting—Estropipate—osteoporosis	0.000281	0.000821	CcSEcCtD
Ropivacaine—Dizziness—Ibandronate—osteoporosis	0.00028	0.000819	CcSEcCtD
Ropivacaine—Rash—Estropipate—osteoporosis	0.000278	0.000815	CcSEcCtD
Ropivacaine—Dermatitis—Estropipate—osteoporosis	0.000278	0.000814	CcSEcCtD
Ropivacaine—Nervousness—Estradiol—osteoporosis	0.000278	0.000813	CcSEcCtD
Ropivacaine—Urticaria—Risedronate—osteoporosis	0.000277	0.000811	CcSEcCtD
Ropivacaine—Back pain—Estradiol—osteoporosis	0.000277	0.00081	CcSEcCtD
Ropivacaine—Headache—Estropipate—osteoporosis	0.000277	0.000809	CcSEcCtD
Ropivacaine—Vomiting—Alendronate—osteoporosis	0.000276	0.000809	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000276	0.000808	CcSEcCtD
Ropivacaine—Body temperature increased—Risedronate—osteoporosis	0.000276	0.000807	CcSEcCtD
Ropivacaine—Abdominal pain—Risedronate—osteoporosis	0.000276	0.000807	CcSEcCtD
Ropivacaine—Muscle spasms—Estradiol—osteoporosis	0.000275	0.000805	CcSEcCtD
Ropivacaine—Rash—Alendronate—osteoporosis	0.000274	0.000802	CcSEcCtD
Ropivacaine—Insomnia—Zoledronate—osteoporosis	0.000274	0.000802	CcSEcCtD
Ropivacaine—Dermatitis—Alendronate—osteoporosis	0.000274	0.000802	CcSEcCtD
Ropivacaine—Feeling abnormal—Pamidronate—osteoporosis	0.000273	0.0008	CcSEcCtD
Ropivacaine—Hypotension—Conjugated Estrogens—osteoporosis	0.000273	0.000798	CcSEcCtD
Ropivacaine—Headache—Alendronate—osteoporosis	0.000272	0.000797	CcSEcCtD
Ropivacaine—Paraesthesia—Zoledronate—osteoporosis	0.000272	0.000796	CcSEcCtD
Ropivacaine—Vomiting—Raloxifene—osteoporosis	0.000272	0.000796	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000271	0.000794	CcSEcCtD
Ropivacaine—Dyspnoea—Zoledronate—osteoporosis	0.00027	0.00079	CcSEcCtD
Ropivacaine—Rash—Raloxifene—osteoporosis	0.00027	0.000789	CcSEcCtD
Ropivacaine—Dermatitis—Raloxifene—osteoporosis	0.000269	0.000788	CcSEcCtD
Ropivacaine—Somnolence—Zoledronate—osteoporosis	0.000269	0.000788	CcSEcCtD
Ropivacaine—Vomiting—Ibandronate—osteoporosis	0.000269	0.000788	CcSEcCtD
Ropivacaine—Tremor—Estradiol—osteoporosis	0.000268	0.000784	CcSEcCtD
Ropivacaine—Headache—Raloxifene—osteoporosis	0.000268	0.000784	CcSEcCtD
Ropivacaine—Rash—Ibandronate—osteoporosis	0.000267	0.000781	CcSEcCtD
Ropivacaine—Dermatitis—Ibandronate—osteoporosis	0.000267	0.00078	CcSEcCtD
Ropivacaine—Dyspepsia—Zoledronate—osteoporosis	0.000267	0.00078	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000266	0.000778	CcSEcCtD
Ropivacaine—Ill-defined disorder—Estradiol—osteoporosis	0.000265	0.000777	CcSEcCtD
Ropivacaine—Headache—Ibandronate—osteoporosis	0.000265	0.000776	CcSEcCtD
Ropivacaine—Insomnia—Conjugated Estrogens—osteoporosis	0.000264	0.000772	CcSEcCtD
Ropivacaine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000264	0.000772	CcSEcCtD
Ropivacaine—Vomiting—Calcitriol—osteoporosis	0.000263	0.000771	CcSEcCtD
Ropivacaine—Agitation—Estradiol—osteoporosis	0.000263	0.000769	CcSEcCtD
Ropivacaine—Nausea—Estropipate—osteoporosis	0.000262	0.000767	CcSEcCtD
Ropivacaine—Abdominal pain—Pamidronate—osteoporosis	0.000262	0.000767	CcSEcCtD
Ropivacaine—Body temperature increased—Pamidronate—osteoporosis	0.000262	0.000767	CcSEcCtD
Ropivacaine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000262	0.000767	CcSEcCtD
Ropivacaine—Angioedema—Estradiol—osteoporosis	0.000261	0.000765	CcSEcCtD
Ropivacaine—Rash—Calcitriol—osteoporosis	0.000261	0.000765	CcSEcCtD
Ropivacaine—Dermatitis—Calcitriol—osteoporosis	0.000261	0.000764	CcSEcCtD
Ropivacaine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00026	0.000761	CcSEcCtD
Ropivacaine—Headache—Calcitriol—osteoporosis	0.00026	0.00076	CcSEcCtD
Ropivacaine—Somnolence—Conjugated Estrogens—osteoporosis	0.000259	0.000759	CcSEcCtD
Ropivacaine—Constipation—Zoledronate—osteoporosis	0.000259	0.000758	CcSEcCtD
Ropivacaine—Pain—Zoledronate—osteoporosis	0.000259	0.000758	CcSEcCtD
Ropivacaine—Nausea—Alendronate—osteoporosis	0.000258	0.000756	CcSEcCtD
Ropivacaine—Malaise—Estradiol—osteoporosis	0.000258	0.000755	CcSEcCtD
Ropivacaine—Hypersensitivity—Risedronate—osteoporosis	0.000257	0.000752	CcSEcCtD
Ropivacaine—Vertigo—Estradiol—osteoporosis	0.000257	0.000752	CcSEcCtD
Ropivacaine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000257	0.000751	CcSEcCtD
Ropivacaine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000257	0.000751	CcSEcCtD
Ropivacaine—Syncope—Estradiol—osteoporosis	0.000256	0.000751	CcSEcCtD
Ropivacaine—Nausea—Raloxifene—osteoporosis	0.000254	0.000743	CcSEcCtD
Ropivacaine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000253	0.000741	CcSEcCtD
Ropivacaine—Nausea—Ibandronate—osteoporosis	0.000251	0.000736	CcSEcCtD
Ropivacaine—Loss of consciousness—Estradiol—osteoporosis	0.000251	0.000736	CcSEcCtD
Ropivacaine—Asthenia—Risedronate—osteoporosis	0.00025	0.000733	CcSEcCtD
Ropivacaine—Feeling abnormal—Zoledronate—osteoporosis	0.00025	0.000731	CcSEcCtD
Ropivacaine—Cough—Estradiol—osteoporosis	0.00025	0.000731	CcSEcCtD
Ropivacaine—Constipation—Conjugated Estrogens—osteoporosis	0.000249	0.00073	CcSEcCtD
Ropivacaine—Pain—Conjugated Estrogens—osteoporosis	0.000249	0.00073	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000248	0.000725	CcSEcCtD
Ropivacaine—Hypertension—Estradiol—osteoporosis	0.000247	0.000723	CcSEcCtD
Ropivacaine—Pruritus—Risedronate—osteoporosis	0.000247	0.000722	CcSEcCtD
Ropivacaine—Nausea—Calcitriol—osteoporosis	0.000246	0.00072	CcSEcCtD
Ropivacaine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000245	0.000717	CcSEcCtD
Ropivacaine—Hypersensitivity—Pamidronate—osteoporosis	0.000244	0.000715	CcSEcCtD
Ropivacaine—Myalgia—Estradiol—osteoporosis	0.000244	0.000713	CcSEcCtD
Ropivacaine—Chest pain—Estradiol—osteoporosis	0.000244	0.000713	CcSEcCtD
Ropivacaine—Arthralgia—Estradiol—osteoporosis	0.000244	0.000713	CcSEcCtD
Ropivacaine—Anxiety—Estradiol—osteoporosis	0.000243	0.00071	CcSEcCtD
Ropivacaine—Urticaria—Zoledronate—osteoporosis	0.000241	0.000704	CcSEcCtD
Ropivacaine—Discomfort—Estradiol—osteoporosis	0.000241	0.000704	CcSEcCtD
Ropivacaine—Body temperature increased—Zoledronate—osteoporosis	0.000239	0.000701	CcSEcCtD
Ropivacaine—Abdominal pain—Zoledronate—osteoporosis	0.000239	0.000701	CcSEcCtD
Ropivacaine—Diarrhoea—Risedronate—osteoporosis	0.000239	0.000699	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000239	0.000698	CcSEcCtD
Ropivacaine—Asthenia—Pamidronate—osteoporosis	0.000238	0.000696	CcSEcCtD
Ropivacaine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000237	0.000693	CcSEcCtD
Ropivacaine—Confusional state—Estradiol—osteoporosis	0.000235	0.000689	CcSEcCtD
Ropivacaine—Pruritus—Pamidronate—osteoporosis	0.000235	0.000687	CcSEcCtD
Ropivacaine—Anaphylactic shock—Estradiol—osteoporosis	0.000233	0.000683	CcSEcCtD
Ropivacaine—Infection—Estradiol—osteoporosis	0.000232	0.000679	CcSEcCtD
Ropivacaine—Urticaria—Conjugated Estrogens—osteoporosis	0.000232	0.000678	CcSEcCtD
Ropivacaine—Dizziness—Risedronate—osteoporosis	0.000231	0.000675	CcSEcCtD
Ropivacaine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000231	0.000675	CcSEcCtD
Ropivacaine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000231	0.000675	CcSEcCtD
Ropivacaine—Shock—Estradiol—osteoporosis	0.00023	0.000672	CcSEcCtD
Ropivacaine—Tachycardia—Estradiol—osteoporosis	0.000228	0.000667	CcSEcCtD
Ropivacaine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000227	0.000666	CcSEcCtD
Ropivacaine—Diarrhoea—Pamidronate—osteoporosis	0.000227	0.000664	CcSEcCtD
Ropivacaine—Skin disorder—Estradiol—osteoporosis	0.000227	0.000664	CcSEcCtD
Ropivacaine—Hyperhidrosis—Estradiol—osteoporosis	0.000226	0.000661	CcSEcCtD
Ropivacaine—Rash—Ethinyl Estradiol—osteoporosis	0.000226	0.00066	CcSEcCtD
Ropivacaine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000225	0.00066	CcSEcCtD
Ropivacaine—Headache—Ethinyl Estradiol—osteoporosis	0.000224	0.000656	CcSEcCtD
Ropivacaine—Hypersensitivity—Zoledronate—osteoporosis	0.000223	0.000653	CcSEcCtD
Ropivacaine—Vomiting—Risedronate—osteoporosis	0.000222	0.000649	CcSEcCtD
Ropivacaine—Rash—Risedronate—osteoporosis	0.00022	0.000644	CcSEcCtD
Ropivacaine—Dermatitis—Risedronate—osteoporosis	0.00022	0.000643	CcSEcCtD
Ropivacaine—Dizziness—Pamidronate—osteoporosis	0.000219	0.000642	CcSEcCtD
Ropivacaine—Headache—Risedronate—osteoporosis	0.000219	0.00064	CcSEcCtD
Ropivacaine—Asthenia—Zoledronate—osteoporosis	0.000217	0.000636	CcSEcCtD
Ropivacaine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000215	0.000629	CcSEcCtD
Ropivacaine—Pruritus—Zoledronate—osteoporosis	0.000214	0.000627	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000213	0.000622	CcSEcCtD
Ropivacaine—Nausea—Ethinyl Estradiol—osteoporosis	0.000213	0.000622	CcSEcCtD
Ropivacaine—Insomnia—Estradiol—osteoporosis	0.000211	0.000618	CcSEcCtD
Ropivacaine—Vomiting—Pamidronate—osteoporosis	0.000211	0.000617	CcSEcCtD
Ropivacaine—Paraesthesia—Estradiol—osteoporosis	0.00021	0.000614	CcSEcCtD
Ropivacaine—Asthenia—Conjugated Estrogens—osteoporosis	0.000209	0.000613	CcSEcCtD
Ropivacaine—Rash—Pamidronate—osteoporosis	0.000209	0.000612	CcSEcCtD
Ropivacaine—Dermatitis—Pamidronate—osteoporosis	0.000209	0.000611	CcSEcCtD
Ropivacaine—Dyspnoea—Estradiol—osteoporosis	0.000208	0.000609	CcSEcCtD
Ropivacaine—Headache—Pamidronate—osteoporosis	0.000208	0.000608	CcSEcCtD
Ropivacaine—Somnolence—Estradiol—osteoporosis	0.000208	0.000607	CcSEcCtD
Ropivacaine—Diarrhoea—Zoledronate—osteoporosis	0.000207	0.000607	CcSEcCtD
Ropivacaine—Nausea—Risedronate—osteoporosis	0.000207	0.000606	CcSEcCtD
Ropivacaine—Pruritus—Conjugated Estrogens—osteoporosis	0.000206	0.000604	CcSEcCtD
Ropivacaine—Dyspepsia—Estradiol—osteoporosis	0.000205	0.000601	CcSEcCtD
Ropivacaine—Dizziness—Zoledronate—osteoporosis	0.0002	0.000586	CcSEcCtD
Ropivacaine—Constipation—Estradiol—osteoporosis	0.0002	0.000584	CcSEcCtD
Ropivacaine—Pain—Estradiol—osteoporosis	0.0002	0.000584	CcSEcCtD
Ropivacaine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.0002	0.000584	CcSEcCtD
Ropivacaine—Nausea—Pamidronate—osteoporosis	0.000197	0.000577	CcSEcCtD
Ropivacaine—Dizziness—Conjugated Estrogens—osteoporosis	0.000193	0.000565	CcSEcCtD
Ropivacaine—Vomiting—Zoledronate—osteoporosis	0.000193	0.000564	CcSEcCtD
Ropivacaine—Feeling abnormal—Estradiol—osteoporosis	0.000192	0.000563	CcSEcCtD
Ropivacaine—Rash—Zoledronate—osteoporosis	0.000191	0.000559	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Estradiol—osteoporosis	0.000191	0.000559	CcSEcCtD
Ropivacaine—Dermatitis—Zoledronate—osteoporosis	0.000191	0.000559	CcSEcCtD
Ropivacaine—Headache—Zoledronate—osteoporosis	0.00019	0.000555	CcSEcCtD
Ropivacaine—Vomiting—Conjugated Estrogens—osteoporosis	0.000185	0.000543	CcSEcCtD
Ropivacaine—Urticaria—Estradiol—osteoporosis	0.000185	0.000543	CcSEcCtD
Ropivacaine—Abdominal pain—Estradiol—osteoporosis	0.000185	0.00054	CcSEcCtD
Ropivacaine—Body temperature increased—Estradiol—osteoporosis	0.000185	0.00054	CcSEcCtD
Ropivacaine—Rash—Conjugated Estrogens—osteoporosis	0.000184	0.000538	CcSEcCtD
Ropivacaine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000184	0.000538	CcSEcCtD
Ropivacaine—Headache—Conjugated Estrogens—osteoporosis	0.000183	0.000535	CcSEcCtD
Ropivacaine—Nausea—Zoledronate—osteoporosis	0.00018	0.000527	CcSEcCtD
Ropivacaine—Nausea—Conjugated Estrogens—osteoporosis	0.000173	0.000507	CcSEcCtD
Ropivacaine—Hypersensitivity—Estradiol—osteoporosis	0.000172	0.000503	CcSEcCtD
Ropivacaine—Asthenia—Estradiol—osteoporosis	0.000167	0.00049	CcSEcCtD
Ropivacaine—Pruritus—Estradiol—osteoporosis	0.000165	0.000483	CcSEcCtD
Ropivacaine—Diarrhoea—Estradiol—osteoporosis	0.00016	0.000467	CcSEcCtD
Ropivacaine—Dizziness—Estradiol—osteoporosis	0.000154	0.000452	CcSEcCtD
Ropivacaine—Vomiting—Estradiol—osteoporosis	0.000148	0.000434	CcSEcCtD
Ropivacaine—Rash—Estradiol—osteoporosis	0.000147	0.000431	CcSEcCtD
Ropivacaine—Dermatitis—Estradiol—osteoporosis	0.000147	0.00043	CcSEcCtD
Ropivacaine—Headache—Estradiol—osteoporosis	0.000146	0.000428	CcSEcCtD
Ropivacaine—Nausea—Estradiol—osteoporosis	0.000139	0.000406	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—ACTG1—osteoporosis	0.000128	0.00706	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TLN1—osteoporosis	0.000124	0.00684	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—WNT1—osteoporosis	0.000123	0.0068	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ACTG1—osteoporosis	0.000122	0.00675	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000119	0.00657	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TLN1—osteoporosis	0.000119	0.00657	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TLN1—osteoporosis	0.000119	0.00657	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ACTG1—osteoporosis	0.000117	0.00649	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ACTG1—osteoporosis	0.000117	0.00649	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000116	0.00644	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000115	0.00636	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TLN1—osteoporosis	0.000115	0.00634	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TLN1—osteoporosis	0.000115	0.00634	CbGpPWpGaD
Ropivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000113	0.00626	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ACTG1—osteoporosis	0.000113	0.00625	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ACTG1—osteoporosis	0.000113	0.00625	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—TLN1—osteoporosis	0.000113	0.00625	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000111	0.00616	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ACTG1—osteoporosis	0.000111	0.00616	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000104	0.00575	CbGpPWpGaD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000102	0.00567	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—WNT1—osteoporosis	9.93e-05	0.0055	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—WNT1—osteoporosis	9.5e-05	0.00526	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.43e-05	0.00522	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—WNT1—osteoporosis	9.13e-05	0.00505	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—WNT1—osteoporosis	9.13e-05	0.00505	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	8.98e-05	0.00497	CbGpPWpGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—osteoporosis	8.87e-05	0.00491	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	8.86e-05	0.0049	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—WNT1—osteoporosis	8.8e-05	0.00487	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—WNT1—osteoporosis	8.8e-05	0.00487	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP27A1—osteoporosis	8.51e-05	0.00471	CbGpPWpGaD
Ropivacaine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	8.46e-05	0.00468	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	8.41e-05	0.00466	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.41e-05	0.00466	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP27A1—osteoporosis	8.39e-05	0.00464	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TLN1—osteoporosis	8.05e-05	0.00446	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ACTG1—osteoporosis	7.94e-05	0.0044	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	7.56e-05	0.00418	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	7.28e-05	0.00403	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.21e-05	0.00399	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.12e-05	0.00394	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6R—osteoporosis	6.99e-05	0.00387	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	6.49e-05	0.00359	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6R—osteoporosis	6.32e-05	0.0035	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.24e-05	0.00345	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—WNT1—osteoporosis	6.19e-05	0.00343	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.11e-05	0.00338	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.03e-05	0.00334	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—LEP—osteoporosis	5.96e-05	0.0033	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	5.91e-05	0.00327	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.85e-05	0.00324	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	5.83e-05	0.00323	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	5.83e-05	0.00323	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	5.76e-05	0.00319	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6R—osteoporosis	5.66e-05	0.00313	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6R—osteoporosis	5.41e-05	0.00299	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6R—osteoporosis	5.2e-05	0.00288	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6R—osteoporosis	5.2e-05	0.00288	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.06e-05	0.0028	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	5.05e-05	0.00279	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6R—osteoporosis	5.01e-05	0.00277	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6R—osteoporosis	5.01e-05	0.00277	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	5.01e-05	0.00277	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6R—osteoporosis	4.99e-05	0.00276	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.95e-05	0.00274	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	4.94e-05	0.00273	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—LEP—osteoporosis	4.82e-05	0.00267	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.81e-05	0.00266	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.72e-05	0.00261	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.65e-05	0.00258	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—LEP—osteoporosis	4.61e-05	0.00255	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	4.47e-05	0.00247	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—LEP—osteoporosis	4.43e-05	0.00245	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—LEP—osteoporosis	4.43e-05	0.00245	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	4.41e-05	0.00244	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.34e-05	0.0024	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—LEP—osteoporosis	4.27e-05	0.00236	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—LEP—osteoporosis	4.27e-05	0.00236	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6R—osteoporosis	4.04e-05	0.00223	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.87e-05	0.00214	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6R—osteoporosis	3.86e-05	0.00214	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.82e-05	0.00212	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.81e-05	0.00211	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6R—osteoporosis	3.71e-05	0.00205	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6R—osteoporosis	3.71e-05	0.00205	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.67e-05	0.00203	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6R—osteoporosis	3.58e-05	0.00198	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6R—osteoporosis	3.58e-05	0.00198	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6R—osteoporosis	3.52e-05	0.00195	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.51e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	3.49e-05	0.00193	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	3.37e-05	0.00187	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.35e-05	0.00185	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.18e-05	0.00176	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—osteoporosis	3.12e-05	0.00172	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	3.11e-05	0.00172	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	3.06e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LEP—osteoporosis	3e-05	0.00166	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.98e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TGFB1—osteoporosis	2.95e-05	0.00163	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.83e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	2.82e-05	0.00156	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—osteoporosis	2.76e-05	0.00152	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—POMC—osteoporosis	2.69e-05	0.00149	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.63e-05	0.00146	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.63e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.62e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.6e-05	0.00144	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PKM—osteoporosis	2.53e-05	0.0014	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—FDPS—osteoporosis	2.53e-05	0.0014	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—osteoporosis	2.52e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6R—osteoporosis	2.51e-05	0.00139	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.47e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.45e-05	0.00135	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.45e-05	0.00135	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—osteoporosis	2.41e-05	0.00133	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.41e-05	0.00133	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPD2—osteoporosis	2.4e-05	0.00133	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PGLS—osteoporosis	2.4e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—osteoporosis	2.39e-05	0.00132	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—osteoporosis	2.32e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—osteoporosis	2.32e-05	0.00128	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.3e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—osteoporosis	2.28e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—osteoporosis	2.23e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—osteoporosis	2.23e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—osteoporosis	2.23e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—osteoporosis	2.22e-05	0.00123	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ATIC—osteoporosis	2.2e-05	0.00122	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PNP—osteoporosis	2.2e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—osteoporosis	2.19e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—osteoporosis	2.19e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—osteoporosis	2.13e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—osteoporosis	2.11e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—osteoporosis	2.11e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—osteoporosis	2.05e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—osteoporosis	2.05e-05	0.00113	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.03e-05	0.00112	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—osteoporosis	1.97e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—osteoporosis	1.97e-05	0.00109	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.92e-05	0.00106	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—OXCT1—osteoporosis	1.87e-05	0.00103	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CA2—osteoporosis	1.87e-05	0.00103	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—POMC—osteoporosis	1.87e-05	0.00103	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MGLL—osteoporosis	1.82e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—osteoporosis	1.8e-05	0.000995	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FDPS—osteoporosis	1.76e-05	0.000975	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PKM—osteoporosis	1.76e-05	0.000975	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—osteoporosis	1.72e-05	0.000952	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPD2—osteoporosis	1.67e-05	0.000924	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PGLS—osteoporosis	1.67e-05	0.000924	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—osteoporosis	1.65e-05	0.000915	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—osteoporosis	1.65e-05	0.000915	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.64e-05	0.000905	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—osteoporosis	1.59e-05	0.000882	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—osteoporosis	1.59e-05	0.000882	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—POMC—osteoporosis	1.58e-05	0.000875	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—osteoporosis	1.57e-05	0.000869	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH2—osteoporosis	1.55e-05	0.000857	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ATIC—osteoporosis	1.53e-05	0.000845	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PNP—osteoporosis	1.53e-05	0.000845	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FDPS—osteoporosis	1.49e-05	0.000826	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PKM—osteoporosis	1.49e-05	0.000826	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—osteoporosis	1.49e-05	0.000823	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.46e-05	0.000805	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ACP5—osteoporosis	1.42e-05	0.000783	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PGLS—osteoporosis	1.41e-05	0.000783	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPD2—osteoporosis	1.41e-05	0.000783	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—osteoporosis	1.39e-05	0.000768	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TPI1—osteoporosis	1.32e-05	0.000728	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CA2—osteoporosis	1.3e-05	0.000719	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.3e-05	0.000719	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ATIC—osteoporosis	1.29e-05	0.000716	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PNP—osteoporosis	1.29e-05	0.000716	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MGLL—osteoporosis	1.27e-05	0.0007	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—P4HB—osteoporosis	1.24e-05	0.000685	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.22e-05	0.000676	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GAPDH—osteoporosis	1.21e-05	0.000672	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RAP1A—osteoporosis	1.18e-05	0.000655	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FDPS—osteoporosis	1.15e-05	0.000637	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PKM—osteoporosis	1.15e-05	0.000637	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—osteoporosis	1.12e-05	0.00062	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.1e-05	0.000609	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CA2—osteoporosis	1.1e-05	0.000609	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PGLS—osteoporosis	1.09e-05	0.000604	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPD2—osteoporosis	1.09e-05	0.000604	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH2—osteoporosis	1.08e-05	0.000595	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MGLL—osteoporosis	1.07e-05	0.000593	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.01e-05	0.00056	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.01e-05	0.000559	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PNP—osteoporosis	9.98e-06	0.000553	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ATIC—osteoporosis	9.98e-06	0.000553	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ACP5—osteoporosis	9.84e-06	0.000545	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO1—osteoporosis	9.56e-06	0.000529	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMA5—osteoporosis	9.42e-06	0.000522	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMA2—osteoporosis	9.42e-06	0.000522	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TPI1—osteoporosis	9.15e-06	0.000506	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH2—osteoporosis	9.11e-06	0.000504	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—P4HB—osteoporosis	8.6e-06	0.000476	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP27A1—osteoporosis	8.57e-06	0.000474	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CA2—osteoporosis	8.49e-06	0.00047	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—OXCT1—osteoporosis	8.49e-06	0.00047	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GAPDH—osteoporosis	8.44e-06	0.000467	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ACP5—osteoporosis	8.33e-06	0.000461	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MGLL—osteoporosis	8.27e-06	0.000458	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.23e-06	0.000455	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RAP1A—osteoporosis	8.22e-06	0.000455	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TPI1—osteoporosis	7.75e-06	0.000429	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP19A1—osteoporosis	7.64e-06	0.000423	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—P4HB—osteoporosis	7.29e-06	0.000403	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GAPDH—osteoporosis	7.15e-06	0.000396	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH2—osteoporosis	7.03e-06	0.000389	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RAP1A—osteoporosis	6.96e-06	0.000385	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO1—osteoporosis	6.65e-06	0.000368	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.61e-06	0.000366	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMA5—osteoporosis	6.55e-06	0.000362	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMA2—osteoporosis	6.55e-06	0.000362	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ACP5—osteoporosis	6.43e-06	0.000356	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADCY5—osteoporosis	6.25e-06	0.000346	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—osteoporosis	6.22e-06	0.000345	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.07e-06	0.000336	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TPI1—osteoporosis	5.98e-06	0.000331	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—osteoporosis	5.74e-06	0.000318	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO1—osteoporosis	5.63e-06	0.000312	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—P4HB—osteoporosis	5.62e-06	0.000311	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMA5—osteoporosis	5.55e-06	0.000307	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMA2—osteoporosis	5.55e-06	0.000307	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GAPDH—osteoporosis	5.52e-06	0.000305	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RAP1A—osteoporosis	5.38e-06	0.000298	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.31e-06	0.000294	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POMC—osteoporosis	4.59e-06	0.000254	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP19A1—osteoporosis	4.5e-06	0.000249	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO1—osteoporosis	4.34e-06	0.00024	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.34e-06	0.00024	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—osteoporosis	4.33e-06	0.000239	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMA5—osteoporosis	4.28e-06	0.000237	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMA2—osteoporosis	4.28e-06	0.000237	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—osteoporosis	3.99e-06	0.000221	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADCY5—osteoporosis	3.68e-06	0.000204	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—osteoporosis	3.66e-06	0.000203	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.47e-06	0.000192	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—osteoporosis	3.38e-06	0.000187	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POMC—osteoporosis	3.19e-06	0.000177	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADCY5—osteoporosis	2.84e-06	0.000157	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—osteoporosis	2.83e-06	0.000157	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POMC—osteoporosis	2.7e-06	0.00015	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.61e-06	0.000144	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POMC—osteoporosis	2.09e-06	0.000116	CbGpPWpGaD
